Tenders / Winners / United Kingdom
CELIX PHARMA LTD: public contracts won
CELIX PHARMA LTD won 6 public contract awards from 2 public buyers between 2025-11-26 and 2026-06-30. Source: Arcadium Data, data as of .
Contracts ending in the next 18 months
| Ends | Contract | Buyer | Value | End date basis |
|---|---|---|---|---|
| 2027-09-30 | NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | NHS England (GB) | €29.8M | end date stated |
| 2027-09-30 | NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | NHS England (GB) | €17.0M | end date stated |
| 2027-09-30 | NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | NHS England (GB) | €17.0M | end date stated |
| 2027-09-30 | NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | NHS England (GB) | €29.4M | end date stated |
Contracts ending = award notices naming CELIX PHARMA LTD whose contract period ends in the next 18 months: the end date the notice states, else its start or signature date plus the stated duration. 4 contracts.
Awards per month
Contract award notices naming CELIX PHARMA LTD as a winner, by publication month, 2023-11 to 2026-10.
Top public buyers
| Buyer | Awards |
|---|---|
| NHS England | 4 |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 2 |
Sectors (CPV divisions)
| Sector | CPV | Awards |
|---|---|---|
| Medical equipment and pharmaceuticals | 33 | 6 |
Buyer countries
| Country | Awards |
|---|---|
| United Kingdom | 6 |
Recent awards
| Published | Contract | Buyer | Value |
|---|---|---|---|
| 2026-06-30 | Transitional Drugs 7 (9 winners) | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | €19.5M |
| 2026-06-05 | Transitional Drugs 7 (8 winners) | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | €19.5M |
| 2026-04-24 | NHS National Framework for Transition Products (Nintedanib and Dalbavancin) (6 winners) | NHS England | €17.0M |
| 2026-02-25 | NHS National Framework for Transition Products (Nintedanib and Dalbavancin) (7 winners) | NHS England | €17.0M |
| 2026-01-30 | NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin (9 winners) | NHS England | €29.8M |
| 2025-11-26 | NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin (8 winners) | NHS England | €29.4M |
Value = the awarded value the notice states, in EUR (converted at the notice date). A notice with several winners or lots states one total for all of them: it is shown per notice in the table but left out of "value won alone". Grouped by company name and winner country; not matched to a website yet.
Track public contracts
Get every new call for tender and contract award in your sectors and countries, keyed by winner domain: a daily feed, the REST API and an MCP server for AI agents. Free to start, no card.
Source: Arcadium Data tenders database, 3,611,641 official public procurement notices from EU TED and UK Find a Tender, read through their open-data APIs (no logins). Winners that could be a private person (sole traders) are withheld; buyers are public bodies. Data as of 2026-10-26.
Questions
How many public contracts has CELIX PHARMA LTD won?
CELIX PHARMA LTD won 6 public contract awards published between 2025-11-26 and 2026-06-30, from 2 public buyers (official notices in EU TED and UK Find a Tender, as of 2026-10-26).
Who are CELIX PHARMA LTD's biggest public-sector customers?
The public buyers that awarded CELIX PHARMA LTD the most contracts are NHS England (4) and NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (2) (awards, as of 2026-10-26).
What does CELIX PHARMA LTD supply to the public sector?
Most of CELIX PHARMA LTD's awards are in Medical equipment and pharmaceuticals (CPV 33) (6) as of 2026-10-26.
Cite as: Arcadium Data, "CELIX PHARMA LTD public tenders won: 6 contract awards", https://arcadiumdata.io/tenders/winners/celix-pharma-ltd-gb/, data as of 2026-10-26.